Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Malachite Innovations, Inc. (MLCT : OTC)

• Company Description    Malachite Innovations Inc. is a socially-conscious company dedicated to improving the health and wellness of people and our planet. Malachite Innovations Inc., formerly known as Vitality Biopharma Inc., is headquartered in Cleveland, Ohio. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $0.20 Daily Weekly Monthly 20 Day Moving Average: 22,551 shares Shares Outstanding: 51.45 (millions) Market Capitalization: $10.55 (millions) Beta: 3.41 52 Week High: $0.85 52 Week Low: $0.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.76% 16.79% 12 Week 2.50% 10.39% Year To Date -21.15% -4.22%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 200 PARK AVENUE SUITE 400 - CLEVELAND,OH 44122 USA ph: 530-231-7800 fax: - info@vitality.bio http://www.malachiteinnovations.com

• General Corporate Information    Officers Michael Cavanaugh - Chief Executive Officer and Director Edward Feighan - Chairman Richard McKilligan - Chief Financial Officer Richard Celeste - Director - - - Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 56089M107 SIC: 8731 Fiscal Year Fiscal Year End: March Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/12/22 Share - Related Items Shares Outstanding: 51.45 Most Recent Split Date: 7.00 (0.10:1) Beta: 3.41 Market Capitalization: $10.55 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - -854.57 09/30/21 - -143.50 ROA 03/31/22 - -1,241.59 12/31/21 - -438.63 09/30/21 - -112.00 Current Ratio 03/31/22 - 0.34 12/31/21 - 0.51 09/30/21 - 0.37 Quick Ratio 03/31/22 - 0.34 12/31/21 - 0.51 09/30/21 - 0.37 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - -0.02 12/31/21 - -0.01 09/30/21 - 0.00 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©